UNSPSC 51352436: Ethinylestradiol/cyproterone acetate

Ethinylestradiol/cyproterone acetate (EE/CPA), also known as co-cyprindiol is a combination of ethinylestradiol (EE), an estrogen, and cyproterone acetate (CPA), a progestin and antiandrogen, which is used as a birth control pill to prevent pregnancy in women.

UNSPSC 51352436 Ethinylestradiol/cyproterone acetate is a Commodity code designating a specific pharmaceutical product—a hormonal contraceptive combining ethinylestradiol and cyproterone acetate—yet the recent state and local opportunities posted under this code do not reflect procurement of this medication itself. Instead, the tagged solicitations span emergency medical services software, long-term care pharmacy services, general procurement conferences, aquatic facility operations, pharmacy benefits network qualification, opioid-response programs, forensic drug standards, and local EMS pharmaceutical distribution, none of which align with the acquisition of ethinylestradiol/cyproterone acetate tablets or preparations. The code shows no relevant recent activity for the actual product it names.

The mismatch between the code's nominal scope and the posted opportunities suggests either a cataloging error in how solicitations were tagged or that this particular pharmaceutical is not being actively procured through state and local channels at present. A business development professional evaluating this code should treat it as inactive for current decision-making purposes and confirm with specific issuing bodies—such as state health departments, county public health agencies, or Medicaid programs—whether demand for this contraceptive exists before investing pursuit resources.